SCIGEN

SciGen is a high growth biopharmaceutical company that develops, manufactures and markets recombinant human health care biotechnology derived products. SciGen's focus is in the areas of endocrinology, gastroenterology and immunology. The company's portfolio consists of biosimilar products such as rhuman growth hormone, rhuman insulin and rhuman GCSF. All of SciGen's products have undergone substantial clinical development... SciGen is a Singapore-based company with offices in Australia, China, Korea and Philippines, partners and distributors in all other countries.

Also known as: SciGen (Australia) Pty Ltd, SciGen (Beijing) Biotechnology Co. Ltd, SciGen Korea Ltd, SciGen Pte., SciGen Pte. Ltd.

Primary location: Singapore